Optimal activated clotting time during percutaneous coronary intervention.
Hanratty
C G
CG
Ward
M
M
D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects; D001835:Body Weight; D002986:Clinical Trials as Topic; D015986:Confounding Factors, Epidemiologic; D003627:Data Interpretation, Statistical; D004305:Dose-Response Relationship, Drug; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D015201:Meta-Analysis as Topic; D011183:Postoperative Complications / Q000517:prevention & control; D015203:Reproducibility of Results; D014914:Whole Blood Coagulation Time
D006493:Heparin